📰 Nasdaq Acxp News
Nasdaq Acxp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Acxp. Real-time updates on events, politics, business and more.
November 22, 2023
Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 11.3% of Acurx […]
October 14, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 10,100 shares, an increase of 50.7% from the September 15th total of 6,700 shares. Currently, 0.1% of the company’s shares are sold short. […]
September 29, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, a drop of 51.1% from the August 31st total of 13,700 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio […]
August 22, 2023
Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and vTv Therapeutics (NASDAQ:VTVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a summary of […]
August 16, 2023
Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.01, MarketWatch Earnings reports. During the same quarter last year, the business earned ($0.26) earnings per share. Acurx Pharmaceuticals Stock Down 4.2 % Acurx Pharmaceuticals stock […]
May 31, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 21,200 shares, a decrease of 7.0% from the April 30th total of 22,800 shares. Based on an average daily volume of 31,200 shares, the […]
April 17, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 29,400 shares, a decrease of 52.8% from the March 15th total of 62,300 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average […]
April 15, 2023
HC Wainwright reiterated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $14.00 price target on the stock. Acurx Pharmaceuticals Price Performance ACXP opened at $2.96 on Tuesday. The firm has a 50 day simple […]
April 14, 2023
HC Wainwright reaffirmed their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. Acurx Pharmaceuticals Price Performance Acurx Pharmaceuticals stock opened at $2.86 on Tuesday. The company has a market […]
March 30, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 62,300 shares, an increase of 150.2% from the February 28th total of 24,900 shares. Currently, 0.7% of the company’s shares are short sold. Based on an average […]